Industry Overview of Anti-Snoring Treatment Market

Snoring refers to a noisy breathing sound coming through the nose or mouth of an individual, which is caused by the vibration of the soft tissues of the throat. It is medically treated using surgery or continuous positive airway pressure (CPAP), wherein a mask is worn over the nose or mouth and attached to a machine to deliver a constant flow of air into the nostrils. Snoring can also be cured via lifestyle changes, including maintaining body weight, relieving nasal obstruction, changing sleep positions, and avoiding alcohol and sedating medications.

How Big Is the Anti-Snoring Treatment Market?

The global anti-snoring treatment market size reached US$ 1.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2028, exhibiting a growth rate (CAGR) of 9% during 2023-2028.

Global Industry Trends and Drivers:

The increasing technological advancements in devices that support this therapy are primarily driving the anti-snoring treatment market. Furthermore, the rising risk of long-term effects of this noisy breathing, such as fatigue, heart attacks, hypertension, stroke, type 2 diabetes, and decreased blood oxygen levels, is also augmenting the market growth. Apart from this, the escalating demand for this treatment solution as loud and frequent snoring is one of the signs of obstructive sleep apnea (OSA) that can lead to cancer, glaucoma, cognitive and behavioral disorders, and road accidents is positively influencing the global market. Moreover, the widespread adoption of anti-snoring apps, behavioral therapies, dental devices, tongue stabilizing devices (TSD), and mandibular advancing devices (MAD), also known as jaw advancing devices (JAD), for a noisy breathing treatment, which is further bolstering the market growth. Besides this, sedentary lifestyles and unhealthy dietary habits are acting as significant growth-inducing factors. Additionally, the increasing tobacco and alcohol consumption and the growing prevalence of sleep disorders among the population are expected to drive the anti-snoring treatment market in the coming years.

Report Segmentation:

The report has been segmented the market into following categories:

Breakup by Device Type:

  • Mandibular Advancement Devices (MAD)
  • Tongue Stabilizing Devices (TSD)
  • Continuous Positive Airway Pressure (CPAP) Devices
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The report provides a comprehensive analysis of the industry key players listed below:

The Major Players in the market are Airway Management Inc., Apnea Sciences Corporation, Fisher & Paykel Healthcare Corporation Limited, Koninklijke Philips N.V., MEDiTAS Ltd., Medtronic plc, Mitsui Chemicals Inc., ResMed Inc., Rotech Healthcare Inc., SomnoMed, The Pure Sleep Company and Tomed GmbH.